Drugs that offer a survival advantage for men with bone metastases resulting from castration-resistant prostate cancer: new and emerging treatment options.

ABSTRACT: A survival benefit has been demonstrated or is under investigation as the primary outcome among certain recently approved agents and investigational agents for men with metastatic castration-resistant prostate cancer that has spread to bone.

SUBMITTER: McCain J 

PROVIDER: S-EPMC3956387 | biostudies-literature | 2014 Feb

REPOSITORIES: biostudies-literature